Last 12 months
Inside the activity.
0 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 8 |
| Sep 2026 | 0 | 5 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 15, 2024 Filed Mar 18, 2024 20:49 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionPerformance Shares · Derivative | 2,923 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000003 · edgardoc.xml · derivative · entry 3 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,847 Underlying: Common Stock · 2,923 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · derivative.exercise_date: One-third of the shares shall vest on each of the first, second, and third anniversaries of the grant date. The vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and thirty percent of the exercise price per share for thirty consecutive trading days. The appreciation must occur within four years from the grant date. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:49 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Tax withholdingCommon Stock | 1,294 | $98.08 | $126,915.52 |
DisclosureSEC source: 0001698998-24-000003 · edgardoc.xml · nonDerivative · entry 2 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,609 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:49 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionCommon Stock | 2,923 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000003 · edgardoc.xml · nonDerivative · entry 1 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:46 UTC |
Sousa BenChief Information Officer
|
Exercise / conversionCommon Stock · Derivative | 1,299 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002013412-24-000004 · edgardoc.xml · derivative · entry 3 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,599 Underlying: Common Stock · 1,299 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F4 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:46 UTC |
Sousa BenChief Information Officer
|
Tax withholdingCommon Stock | 463 | $98.08 | $45,411.04 |
DisclosureSEC source: 0002013412-24-000004 · edgardoc.xml · nonDerivative · entry 2 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,319 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:46 UTC |
Sousa BenChief Information Officer
|
Exercise / conversionCommon Stock | 1,299 | $0.00 | $0.00 |
DisclosureSEC source: 0002013412-24-000004 · edgardoc.xml · nonDerivative · entry 1 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:35 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionCommon Stock · Derivative | 3,247 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000002 · edgardoc.xml · derivative · entry 3 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,496 Underlying: Common Stock · 3,247 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:35 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 1,780 | $98.08 | $174,582.40 |
DisclosureSEC source: 0001804831-24-000002 · edgardoc.xml · nonDerivative · entry 2 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,954 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:35 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionCommon Stock | 3,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000002 · edgardoc.xml · nonDerivative · entry 1 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:44 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionCommon Stock · Derivative | 1,624 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000002 · edgardoc.xml · derivative · entry 3 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,248 Underlying: Common Stock · 1,624 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:44 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Tax withholdingCommon Stock | 890 | $98.08 | $87,291.20 |
DisclosureSEC source: 0001669639-24-000002 · edgardoc.xml · nonDerivative · entry 2 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,532 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:44 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionCommon Stock | 1,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000002 · edgardoc.xml · nonDerivative · entry 1 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,422 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:38 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock · Derivative | 4,871 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000003 · edgardoc.xml · derivative · entry 4 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,744 Underlying: Common Stock · 4,871 shares Expires 2026-03-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F3 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. These awards were legally granted on March 15, 2023 but were subject to shareholder approval on May 17, 2023. Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:38 UTC |
Jain VivekDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 2,671 | $98.08 | $261,971.68 |
DisclosureSEC source: 0001410442-24-000003 · edgardoc.xml · nonDerivative · entry 2 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,593 Read SEC document |
| March 15, 2024 Filed Mar 18, 2024 20:38 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 4,871 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000003 · edgardoc.xml · nonDerivative · entry 1 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,264 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 14, 2024 Filed Mar 14, 2024 22:13 UTC |
LOPEZ GEORGE ADirector
|
SaleCommon Stock | 7,978 | $101.87 | $812,741.20 |
DisclosureSEC source: 0001073397-24-000004 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Partnership Disclosed balance after: 877,343 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 12, 2024 Filed Mar 13, 2024 20:09 UTC |
LOPEZ GEORGE ADirector
|
SaleCommon Stock | 1,522 | $101.51 | $154,496.70 |
DisclosureSEC source: 0001073397-24-000002 · edgardoc.xml · nonDerivative · entry 2 LOPEZ GEORGE A · CIK 0001073397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 316,231 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 12, 2024 Filed Mar 14, 2024 16:16 UTC Amendment |
LOPEZ GEORGE ADirector
|
SaleCommon Stock | 1,522 | $101.51 | $154,496.70 |
DisclosureSEC source: 0001073397-24-000003 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · by Partnership Disclosed balance after: 885,321 F1 · price: All shares sold were sold at the exact price disclosed. F2 · ownership.nature: The original Form 4 filed on March 13, 2024, is being amended by this Form 4 amendment solely to correct the ownership form from Direct to Indirect and nature of indirect beneficial ownership to by Partnership. Read SEC document |
| March 11, 2024 Filed Mar 13, 2024 20:09 UTC |
LOPEZ GEORGE ADirector
|
SaleCommon Stock | 1,890 | $104.22 | $196,968.05 |
DisclosureSEC source: 0001073397-24-000002 · edgardoc.xml · nonDerivative · entry 1 LOPEZ GEORGE A · CIK 0001073397 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 317,753 F1 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:35 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionPerformance Shares · Derivative | 2,020 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 10 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,020 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:35 UTC |
Woolson DanielVP, GM-Infusion Capital
|
GrantCommon Stock · Derivative | 6,459 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · derivative · entry 8 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,459 Underlying: Common Stock · 6,459 shares Expires not disclosed F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:35 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Tax withholdingCommon Stock | 894 | $104.52 | $93,440.88 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 6 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,771 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:35 UTC |
Woolson DanielVP, GM-Infusion Capital
|
Exercise / conversionCommon Stock | 2,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001698998-24-000001 · edgardoc.xml · nonDerivative · entry 5 Woolson Daniel · CIK 0001698998 · VP, GM-Infusion Capital 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,665 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:33 UTC |
Sousa BenChief Information Officer
|
GrantCommon Stock · Derivative | 2,871 | $0.00 | $0.00 |
DisclosureSEC source: 0002013412-24-000003 · edgardoc.xml · derivative · entry 9 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,871 Underlying: Common Stock · 2,871 shares Expires not disclosed F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:33 UTC |
Sousa BenChief Information Officer
|
Exercise / conversionCommon Stock · Derivative | 674 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0002013412-24-000003 · edgardoc.xml · derivative · entry 7 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 674 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:33 UTC |
Sousa BenChief Information Officer
|
Tax withholdingCommon Stock | 240 | $104.52 | $25,084.80 |
DisclosureSEC source: 0002013412-24-000003 · edgardoc.xml · nonDerivative · entry 6 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,483 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:33 UTC |
Sousa BenChief Information Officer
|
Exercise / conversionCommon Stock | 674 | $0.00 | $0.00 |
DisclosureSEC source: 0002013412-24-000003 · edgardoc.xml · nonDerivative · entry 5 Sousa Ben · CIK 0002013412 · Chief Information Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,723 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:32 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionPerformance Shares · Derivative | 7,289 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001727477-24-000002 · edgardoc.xml · derivative · entry 12 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,289 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:32 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock · Derivative | 2,210 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001727477-24-000002 · edgardoc.xml · derivative · entry 9 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,210 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:32 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Tax withholdingCommon Stock | 3,998 | $104.52 | $417,870.96 |
DisclosureSEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 8 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,072 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:32 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 7,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 7 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:32 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Tax withholdingCommon Stock | 1,212 | $104.52 | $126,678.24 |
DisclosureSEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 6 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,781 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:32 UTC |
Voigtlander Christian B.Chief Operating Officer
|
Exercise / conversionCommon Stock | 2,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001727477-24-000002 · edgardoc.xml · nonDerivative · entry 5 Voigtlander Christian B. · CIK 0001727477 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionPerformance Shares · Derivative | 7,289 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 12 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,289 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionCommon Stock · Derivative | 2,210 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · derivative · entry 9 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,210 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 3,998 | $104.52 | $417,870.96 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 8 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,487 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionCommon Stock | 7,289 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 7 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,485 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Tax withholdingCommon Stock | 1,212 | $104.52 | $126,678.24 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 6 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,196 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:28 UTC |
Bonnell Brian MichaelChief Financial Officer
|
Exercise / conversionCommon Stock | 2,210 | $0.00 | $0.00 |
DisclosureSEC source: 0001804831-24-000001 · edgardoc.xml · nonDerivative · entry 5 Bonnell Brian Michael · CIK 0001804831 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,408 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionPerformance Shares · Derivative | 8,331 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 13 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,331 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F6 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F8 · derivative.exercise_date: These PRSUs were granted on March 8, 2021 and had a 3-Year cliff-vest subject to the satisfaction of performance-based metrics and continuous services through the vest date. The PRSUs were approved for vesting in February 2024 by the Compensation Committee at 110% of the original grant. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock · Derivative | 2,525 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · derivative · entry 10 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,525 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. F3 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F4 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F5 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC |
Jain VivekDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 4,569 | $104.52 | $477,551.88 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 8 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,393 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 8,331 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 7 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 106,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC |
Jain VivekDirector · Chairman and CEO
|
Tax withholdingCommon Stock | 1,384 | $104.52 | $144,655.68 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 6 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 98,631 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:26 UTC |
Jain VivekDirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 2,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001410442-24-000002 · edgardoc.xml · nonDerivative · entry 5 Jain Vivek · CIK 0001410442 · Director · Chairman and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,015 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These securities are Restricted Stock Units. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionPerformance Shares · Derivative | 2,273 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 11 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,273 shares Expires 2024-03-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F7 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F9 · derivative.exercise_date: These PRSUs were granted on March 8, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 8 of the first, second, and third year following the year of grant. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC |
Sanzone Virginia RuthVP, General Counsel
|
GrantCommon Stock · Derivative | 9,568 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · derivative · entry 9 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,568 Underlying: Common Stock · 9,568 shares Expires not disclosed F1 · security: These securities are Restricted Stock Units. F4 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the Restricted Stock Units. F5 · derivative.exercise_date: One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date. F6 · derivative.expiration_date: These are restricted stock units that fully vest 3 years from the grant date. Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Tax withholdingCommon Stock | 1,246 | $104.52 | $130,231.92 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 7 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,798 Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC |
Sanzone Virginia RuthVP, General Counsel
|
Exercise / conversionCommon Stock | 2,273 | $0.00 | $0.00 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 6 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: These Securities are Performance-based Restricted Stock Units (PRSU). Read SEC document |
| March 08, 2024 Filed Mar 11, 2024 20:24 UTC |
Sanzone Virginia RuthVP, General Counsel
|
SaleCommon Stock | 3,300 | $104.57 | $345,088.26 |
DisclosureSEC source: 0001669639-24-000001 · edgardoc.xml · nonDerivative · entry 5 Sanzone Virginia Ruth · CIK 0001669639 · VP, General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,771 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $104.54 to $104.84, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.